Genomic, immunological, and clinical analysis of COVID-19 vaccine breakthrough infections in Beijing, China.
J Med Virol
; 94(5): 2237-2249, 2022 May.
Article
in En
| MEDLINE
| ID: mdl-35112366
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
COVID-19
Limits:
Humans
Country/Region as subject:
Asia
Language:
En
Journal:
J Med Virol
Year:
2022
Type:
Article
Affiliation country:
China